[DOI] [PubMed] [Google Scholar] 21.Ryan DH, Lingvay I, Colhoun HM, et al
Related medications in the GLP-1 class have extensive long-term data supporting their safety
Constipation may occur when food intake drops, fluid intake decreases, fiber changes, movement declines, or digestion slows
There are a lot of people out there who can relatemaybe they have had a child, and theyre like, Okay, Ive done everything
The Therapeutic Goods Administration's (TGA) warning covers the following glucagon-like peptide-1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and obesity: Semaglutide, sold as Ozempic, Wegovy Tirzepatide, sold as Mounjaro Dulaglutide, sold as Trulicity Liraglutide, sold as Saxenda The TGA said the products had the potential to cause an eye disorder called non-arteritic anterior ischaemic optic neuropathy (NAION)
District Court for the Northern District of Texas, contends that the FDAs removal of these drugs from the shortage list violated federal law by not following proper procedures, such as notifying affected companies and allowing for public comment
